Walgreens Boots signals turnaround on track as it tops estimates, shares surge
Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter adjusted profit on Friday and indicated that ...
Leerink Partnrs Brokers Raise Earnings Estimates for OmniAb
Investment analysts at Leerink Partnrs lifted their FY2024 earnings per share (EPS) estimates for shares of OmniAb in a report released on Tuesday, January 7th. Leerink Partnrs analyst P. Souda now ...
Compass Therapeutics’ (CMPX) Buy Rating Reiterated at D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) in a research report sent to investors on Wednesday morning,Benzinga reports. D. Boral ...
Amylyx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced the pricing of an underwritten public offering of 17,142,857 shares of its common stock at a public offering ...
manilatimes16h
ROTH Expands Sales and Trading Team with Five Strategic Hires
Matthew Job joined ROTH in October 2024 as Executive Director, Senior Sales Trader. Before joining ROTH, he spent six years ...
bovnews17h
Aquestive Therapeutics Inc (AQST) Stock: Analyzing Its Quiet Power
Notable insider trades include Schobel Alexander Mark, Chief Innovation/Tech Officer at Aquestive Therapeutics Inc (AQST), who sold 50000 shares on Mar 15 ’24, at $6 each, totaling $0.30 million. On ...
Crinetics Pharmaceuticals Receives Buy Rating on Promising Phase 2 Trial Results and Strong Financial Position
In a report released today, Cory Jubinville, PhD from LifeSci Capital maintained a Buy rating on Crinetics Pharmaceuticals (CRNX – Research ...
bovnews18h
Envista Holdings Corp (NVST) Stock Dilemma: A Drop That Has Everyone Talking—What’s the Real Story?
Envista Holdings Corp (NVST) stock saw a decline, ending the day at $19.17 which represents a decrease of $-0.32 or -1.64% from the prior close of $19.49. The stock opened at $19.42 and touched a low ...
FiercePharma23h
FDA cancels adcomm in 'positive' sign for Exelixis’ Cabometyx bid in neuroendocrine tumors: analyst
On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...
Investing17h
Castle Biosciences stock falls following Medicare coverage denial
Shares of Castle Biosciences (NASDAQ: CSTL) tumbled 9% after Novitas, a regional Medicare contractor, finalized its decision not to cover one of the company's cancer tests. The Novitas Medicare ...
Walgreens Boots tops estimates as turnaround efforts take hold
Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter adjusted profit and maintained its annual ...
International Financing Review21h
IFR SNAPSHOT - Strong jobs report kicks off the new year
Nonfarm payrolls increased by 256,000 jobs last month after rising by a downwardly revised 212,000 in November, while the unemployment rate fell to 4.1% from 4.2%, Reuters reported this morning.